Related Experiment Videos
The clinical use of milnacipran for depression
Shigeru Morishita1, Seizaburo Arita
1Department of Psychiatry, Kawasaki Medical School, 577 Matsushima, Kurashiki-city, 701-0192 Okayama, Japan. morisita@med.kawaski-m.ac.jp
Abstract:
We examined the relation between dosage and efficacy, and the predictors of response to milnacipran. There was no difference between 50 and 100 mg dose. However, the 100 mg dose had a faster onset of action than the 50 mg dose. An age and an episode have been predictors of milnacipran.